These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
391 related articles for article (PubMed ID: 18562536)
1. Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infection. Daffis S; Samuel MA; Suthar MS; Keller BC; Gale M; Diamond MS J Virol; 2008 Sep; 82(17):8465-75. PubMed ID: 18562536 [TBL] [Abstract][Full Text] [Related]
2. Cell-specific IRF-3 responses protect against West Nile virus infection by interferon-dependent and -independent mechanisms. Daffis S; Samuel MA; Keller BC; Gale M; Diamond MS PLoS Pathog; 2007 Jul; 3(7):e106. PubMed ID: 17676997 [TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 3 has a protective role against West Nile virus infection. Daffis S; Samuel MA; Suthar MS; Gale M; Diamond MS J Virol; 2008 Nov; 82(21):10349-58. PubMed ID: 18715906 [TBL] [Abstract][Full Text] [Related]
4. Induction of IFN-beta and the innate antiviral response in myeloid cells occurs through an IPS-1-dependent signal that does not require IRF-3 and IRF-7. Daffis S; Suthar MS; Szretter KJ; Gale M; Diamond MS PLoS Pathog; 2009 Oct; 5(10):e1000607. PubMed ID: 19798431 [TBL] [Abstract][Full Text] [Related]
5. IRF-3, IRF-5, and IRF-7 coordinately regulate the type I IFN response in myeloid dendritic cells downstream of MAVS signaling. Lazear HM; Lancaster A; Wilkins C; Suthar MS; Huang A; Vick SC; Clepper L; Thackray L; Brassil MM; Virgin HW; Nikolich-Zugich J; Moses AV; Gale M; Früh K; Diamond MS PLoS Pathog; 2013 Jan; 9(1):e1003118. PubMed ID: 23300459 [TBL] [Abstract][Full Text] [Related]
6. Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. Samuel MA; Diamond MS J Virol; 2005 Nov; 79(21):13350-61. PubMed ID: 16227257 [TBL] [Abstract][Full Text] [Related]
7. A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice. Liu WJ; Wang XJ; Clark DC; Lobigs M; Hall RA; Khromykh AA J Virol; 2006 Mar; 80(5):2396-404. PubMed ID: 16474146 [TBL] [Abstract][Full Text] [Related]
8. Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infection. Shrestha B; Wang T; Samuel MA; Whitby K; Craft J; Fikrig E; Diamond MS J Virol; 2006 Jun; 80(11):5338-48. PubMed ID: 16699014 [TBL] [Abstract][Full Text] [Related]
9. Two Interferon-Stimulated Response Elements Cooperatively Regulate Interferon-Stimulated Gene Expression in West Nile Virus-Infected IFNAR Cui D; Espínola EE; Arora K; Brinton MA J Virol; 2021 Oct; 95(22):e0104021. PubMed ID: 34495694 [TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor alpha protects against lethal West Nile virus infection by promoting trafficking of mononuclear leukocytes into the central nervous system. Shrestha B; Zhang B; Purtha WE; Klein RS; Diamond MS J Virol; 2008 Sep; 82(18):8956-64. PubMed ID: 18632856 [TBL] [Abstract][Full Text] [Related]
11. The Interferon-Stimulated Gene Ifi27l2a Restricts West Nile Virus Infection and Pathogenesis in a Cell-Type- and Region-Specific Manner. Lucas TM; Richner JM; Diamond MS J Virol; 2015 Dec; 90(5):2600-15. PubMed ID: 26699642 [TBL] [Abstract][Full Text] [Related]
12. The Interferon-Stimulated Gene Ifitm3 Restricts West Nile Virus Infection and Pathogenesis. Gorman MJ; Poddar S; Farzan M; Diamond MS J Virol; 2016 Sep; 90(18):8212-25. PubMed ID: 27384652 [TBL] [Abstract][Full Text] [Related]
13. The innate immune adaptor molecule MyD88 restricts West Nile virus replication and spread in neurons of the central nervous system. Szretter KJ; Daffis S; Patel J; Suthar MS; Klein RS; Gale M; Diamond MS J Virol; 2010 Dec; 84(23):12125-38. PubMed ID: 20881045 [TBL] [Abstract][Full Text] [Related]
14. Interferon regulatory factor-1 (IRF-1) shapes both innate and CD8(+) T cell immune responses against West Nile virus infection. Brien JD; Daffis S; Lazear HM; Cho H; Suthar MS; Gale M; Diamond MS PLoS Pathog; 2011 Sep; 7(9):e1002230. PubMed ID: 21909274 [TBL] [Abstract][Full Text] [Related]
15. Establishment and maintenance of the innate antiviral response to West Nile Virus involves both RIG-I and MDA5 signaling through IPS-1. Fredericksen BL; Keller BC; Fornek J; Katze MG; Gale M J Virol; 2008 Jan; 82(2):609-16. PubMed ID: 17977974 [TBL] [Abstract][Full Text] [Related]
16. Interferon regulatory factor 5-dependent immune responses in the draining lymph node protect against West Nile virus infection. Thackray LB; Shrestha B; Richner JM; Miner JJ; Pinto AK; Lazear HM; Gale M; Diamond MS J Virol; 2014 Oct; 88(19):11007-21. PubMed ID: 25031348 [TBL] [Abstract][Full Text] [Related]
17. West Nile virus noncoding subgenomic RNA contributes to viral evasion of the type I interferon-mediated antiviral response. Schuessler A; Funk A; Lazear HM; Cooper DA; Torres S; Daffis S; Jha BK; Kumagai Y; Takeuchi O; Hertzog P; Silverman R; Akira S; Barton DJ; Diamond MS; Khromykh AA J Virol; 2012 May; 86(10):5708-18. PubMed ID: 22379089 [TBL] [Abstract][Full Text] [Related]
18. 2'-O methylation of the viral mRNA cap by West Nile virus evades ifit1-dependent and -independent mechanisms of host restriction in vivo. Szretter KJ; Daniels BP; Cho H; Gainey MD; Yokoyama WM; Gale M; Virgin HW; Klein RS; Sen GC; Diamond MS PLoS Pathog; 2012; 8(5):e1002698. PubMed ID: 22589727 [TBL] [Abstract][Full Text] [Related]
19. Pattern recognition receptor MDA5 modulates CD8+ T cell-dependent clearance of West Nile virus from the central nervous system. Lazear HM; Pinto AK; Ramos HJ; Vick SC; Shrestha B; Suthar MS; Gale M; Diamond MS J Virol; 2013 Nov; 87(21):11401-15. PubMed ID: 23966390 [TBL] [Abstract][Full Text] [Related]
20. PKR and RNase L contribute to protection against lethal West Nile Virus infection by controlling early viral spread in the periphery and replication in neurons. Samuel MA; Whitby K; Keller BC; Marri A; Barchet W; Williams BR; Silverman RH; Gale M; Diamond MS J Virol; 2006 Jul; 80(14):7009-19. PubMed ID: 16809306 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]